US · Healthcare

Cassava Sciences Inc (SAVA)

Biotechnology

Cassava Sciences Inc (SAVA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SAVA

P/E ratio

25.00

Cassava Sciences Inc (SAVA) — FAQ

What is SAVA's P/E ratio?

The price-to-earnings (P/E) ratio for Cassava Sciences Inc (SAVA) is 25.00 (data as of 2026-05-23).

Does Cassava Sciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cassava Sciences Inc (SAVA). Check the MyAverix Finance app for the latest dividend data.

What sector is Cassava Sciences Inc in?

Cassava Sciences Inc (SAVA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SAVA listed on?

SAVA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)